
FibroGen FGEN
Geschäftsbericht 2025
hinzugefügt 16.03.2026
FibroGen ROE 2011-2026 | FGEN
ROE Jährlich FibroGen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -610.73 | 21.09 | 139.22 | 1369.21 | -126.59 | -42.88 | -14.38 | -16.35 | -21.67 | -35.22 | -43.58 | -24.72 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1369.21 | -610.73 | 49.45 |
ROE Vierteljährlich FibroGen
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1159.55 | 26.06 | 29.43 | 75.97 | 114.86 | 214.73 | 419.3 | 221.24 | -23.37 | -189.26 | -292.26 | -277.83 | -65.33 | -54.52 | -51.83 | -44.02 | -50.63 | -22.96 | -30.95 | -39.27 | -55.4 | -16.75 | 0.84 | -7.51 | -7.56 | -30.6 | -21.09 | -25.71 | -21.99 | -23.42 | -16.46 | -31.96 | -42.83 | -21.19 | -17.76 | -43.16 | -53.06 | -36.53 | -19.38 | -37.24 | -29.69 | -40.68 | -4.04 | -4.04 | 13.82 | -7.33 | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 419.3 | -1159.55 | -39.15 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M | ||
|
AgeX Therapeutics
AGE
|
51843.24 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M | ||
|
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | ||
|
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M | ||
|
AlloVir
ALVR
|
-55.11 | - | 4.14 % | $ 49.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
-5.9 | $ 0.88 | -1.69 % | $ 6.47 M | ||
|
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
626.29 | - | 2.54 % | $ 160 B | ||
|
Aquestive Therapeutics
AQST
|
248.9 | $ 4.1 | 1.23 % | $ 438 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
30.9 | $ 22.45 | 1.13 % | $ 3.72 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
-380.03 | - | - | $ 269 M | ||
|
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | ||
|
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
20.44 | - | - | $ 96.9 B | ||
|
Atreca
BCEL
|
-123.92 | - | -11.76 % | $ 5.79 M | ||
|
Berkeley Lights
BLI
|
-69.02 | - | -7.31 % | $ 87 M | ||
|
Calithera Biosciences
CALA
|
-1373.04 | - | -10.95 % | $ 876 K | ||
|
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | ||
|
CymaBay Therapeutics
CBAY
|
-36.05 | - | - | $ 3.45 B | ||
|
ChemoCentryx
CCXI
|
-46.05 | - | - | $ 3.74 B | ||
|
Cerus Corporation
CERS
|
-24.33 | $ 2.03 | 5.73 % | $ 387 M | ||
|
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - | ||
|
Caladrius Biosciences
CLBS
|
-67.58 | - | -16.75 % | $ 25.8 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
-88.4 | - | - | $ 231 M | ||
|
Kazia Therapeutics Limited
KZIA
|
-132.24 | $ 13.64 | 9.82 % | $ 1.81 B | ||
|
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | ||
|
BioNTech SE
BNTX
|
1.11 | $ 103.45 | 1.85 % | $ 27.2 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
103.22 | - | -2.5 % | $ 5.88 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
-55.55 | - | - | $ 2.18 B | ||
|
AIkido Pharma
AIKI
|
-32.34 | - | 1.93 % | $ 17.4 M | ||
|
Innate Pharma S.A.
IPHA
|
-41.02 | $ 1.44 | -3.36 % | $ 235 M | ||
|
Dynavax Technologies Corporation
DVAX
|
4.58 | - | - | $ 2.02 B | ||
|
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
-110.0 | - | - | $ 28.6 M | ||
|
Editas Medicine
EDIT
|
-586.56 | $ 3.0 | 6.38 % | $ 266 M | ||
|
Edesa Biotech
EDSA
|
-311.44 | $ 18.27 | 14.94 % | $ 58.4 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-175.75 | $ 3.19 | 6.69 % | $ 5.25 M | ||
|
Eiger BioPharmaceuticals
EIGR
|
518.49 | - | -9.21 % | $ 2.55 M | ||
|
Eloxx Pharmaceuticals
ELOX
|
338.32 | - | -5.68 % | $ 8.28 M | ||
|
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | ||
|
Applied Therapeutics
APLT
|
698.49 | - | - | $ 8.42 M | ||
|
Aptose Biosciences
APTO
|
93.75 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-169.38 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
-716.17 | - | -13.39 % | $ 1.45 M |